Skip to main content
CVRX
NASDAQ Industrial Applications And Services

CVRx Cuts 2026 Revenue Guidance to $56-57M as Q3 Revenue Falls 6%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.47
Mkt Cap
$39.163M
52W Low
$1.255
52W High
$10.63
52W Position info
17% above low
Off High info
86% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

CVRX sits 17% above its 52-week low of $1.255 on light trading volume (0.4× avg).

Summary

CVRx reported Q3 revenue of $13.8 million, down 6%, and cut full-year 2026 guidance to $56-57 million from $58-60 million. The net loss widened to $14.2 million, leaving $58.7 million of cash.


Key Events · Earnings and Guidance · CVRX

  • Q3 Revenue Falls 6% to $13.8M

    Total revenue was $13.8 million versus $14.7 million a year ago. U.S. revenue fell 4% to $13.0 million on lower sales force productivity and a prolonged challenge with one of its largest payers.

  • Full-Year Guidance Cut

    2026 revenue guidance was lowered to $56.0-$57.0 million from $58.0-$60.0 million, with Q4 guided to $11.7-$12.7 million — below the Q3 run rate.

  • Net Loss Widens to $14.2M

    Net loss was $14.2 million, or $0.52 per share, versus $12.9 million, or $0.49 per share, a year ago. SG&A rose 2% to $22.4 million on higher legal and travel costs.

  • Cash Runway and Cost Cuts

    Cash was $58.7 million at September 30, 2026, with $11.0 million used in operating and investing activities in Q3. The company cut non-commercial functions and pulled back on non-revenue R&D and marketing.


Analysis · CVRX · Industrial Applications And Services

The revenue trajectory is the problem here. CVRx trimmed full-year revenue guidance to $56.0-$57.0 million from $58.0-$60.0 million and guided Q4 to just $11.7-$12.7 million, well below the Q3 run rate. Q3 revenue fell 6% to $13.8 million on lower sales force productivity and a prolonged problem with one of its largest payers, while the net loss widened to $14.2 million. With $58.7 million of cash and $11.0 million burned in the quarter, the company has roughly five quarters of runway before it needs more capital — and it already has a $50 million ATM program in place from January 2026. The cost cuts protect the balance sheet, but they do not fix the top line.

How filings like this one have moved

In the 30 days to Nov 5, 2026, 43.4% of the 1274 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.16%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CVRX was trading at $1.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $39.2M. The 52-week trading range was $1.26 to $10.63. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CVRX - Latest Insights

CVRX
Nov 05, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.31 info
Change: -$0.160 (-11%) info
Market Cap: $39.163M info
CVRX
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.31 info
Change: -$0.160 (-11%) info
Market Cap: $39.163M info
CVRX
Oct 02, 2026, 9:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.53
Real-time Price: $1.31 info
Change: -$0.220 (-14%) info
Market Cap: $39.163M info
CVRX
Sep 21, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.97
Real-time Price: $1.31 info
Change: -$1.66 (-56%) info
Market Cap: $39.163M info
CVRX
Aug 24, 2026, 8:00 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $3.12
Real-time Price: $1.31 info
Change: -$1.81 (-58%) info
Market Cap: $39.163M info